-
EP2139881
European procedure
Extract from the Register of European Patents
EP About this file: EP2139881
| EP2139881 - QUINOLINES AND THEIR THERAPEUTIC USE [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 14.09.2012 Database last updated on 26.07.2024 | Most recent event Tooltip | 14.09.2012 | No opposition filed within time limit | published on 17.10.2012 [2012/42] | Applicant(s) | For all designated states Pulmagen Therapeutics (Asthma) Limited Fulmer Hall Windmill Road Fulmer Slough SL3 6HD / GB | [2011/08] |
| Former [2010/30] | For all designated states Pulmagen Therapeutics (Asthma) Limited Stoke Court Stoke Pages Slough Berkshire SL2 4SY / GB | ||
| Former [2010/01] | For all designated states Argenta Oral Therapeutics Limited Stoke Court Stoke Poges Slough Berkshire SL2 4SY / GB | Inventor(s) | 01 /
MONTANA, John, Gary Argenta Discovery Limited 8/9 Spire Green Centre Flex Meadow Harlow Essex CM19 5TR / GB | 02 /
FINCH, Harry Argenta Discovery Limited 8/9 Spire Green Centre Flex Meadow Harlow Essex CM19 5TR / GB | 03 /
HYND, George Argenta Discovery Limited 8-9 Spire Green Centre Flex Meadow Harlow Essex CM19 5TR / GB | 04 /
CRAMP, Michael, Colin Argenta Discovery Limited 8/9 Spire Green Centre Flex Meadow Harlow Essex CM19 5TR / GB | 05 /
ARIENZO, Rosa Argenta Discovery Limited 8/9 Spire Green Centre Flex Meadow Harlow Essex CM19 5TR / GB | 06 /
MCLEAN, Neville Argenta Discovery Limited 8/9 Spire Green Centre Flex Meadow Harlow Essex CM19 5TR / GB | [2011/45] |
| Former [2010/01] | 01 /
MONTANA, John, Gary Argenta Discovery Limited 8/9 Spire Green Centre Flex Meadow Harlow Essex CM19 5TR / GB | ||
| 02 /
FINCH, Harry Argenta Discovery Limited 8/9 Spire Green Centre Flex Meadow Harlow Essex CM19 5TR / GB | |||
| 03 /
HYND, George Argenta Discovery Limited 8-9 Spire Green Centre Flex Meadow Harlow Essex CM19 5TR / GB | |||
| 04 /
CRAMP, Michael, Colin Argenta Discovery Limited 8/9 Spire Green Centre Flex Meadow Harlow Essex CM19 5TR / GB | |||
| 05 /
ARIENZO, Rosa Argenta Discovery Limited 8/9 Spire Green Centre Flex Meadow Harlow Essex CM19 5TR / GB | |||
| 06 /
MCLEAN, Neville Argenta Discovery Limited 8/9 Spire Green Centre Flex Meadow Harlow Essex CM19 5TR / GB | Representative(s) | Perry, Robert Edward, et al Gill Jennings & Every LLP The Broadgate Tower 20 Primrose Street London EC2A 2ES / GB | [N/P] |
| Former [2010/16] | Perry, Robert Edward, et al Gill Jennings & Every LLP Broadgate House 7 Eldon Street London EC2M 7LH / GB | ||
| Former [2010/01] | Perry, Robert Edward Gill Jennings & Every LLP Broadgate House 7 Eldon Street London EC2M 7LH / GB | Application number, filing date | 08736891.6 | 03.04.2008 | [2010/01] | WO2008GB01201 | Priority number, date | GB20070006636 | 04.04.2007 Original published format: GB 0706636 | GB20070024430 | 14.12.2007 Original published format: GB 0724430 | [2010/01] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2008122784 | Date: | 16.10.2008 | Language: | EN | [2008/42] | Type: | A1 Application with search report | No.: | EP2139881 | Date: | 06.01.2010 | Language: | EN | The application published by WIPO in one of the EPO official languages on 16.10.2008 takes the place of the publication of the European patent application. | [2010/01] | Type: | B1 Patent specification | No.: | EP2139881 | Date: | 09.11.2011 | Language: | EN | [2011/45] | Search report(s) | International search report - published on: | EP | 16.10.2008 | Classification | IPC: | C07D401/10, C07D413/10, C07D417/10, C07D215/227, C07D215/233, A61K31/4709, A61P11/00 | [2010/01] | CPC: |
C07D401/10 (EP,US);
A61P1/00 (EP);
A61P1/04 (EP);
A61P11/00 (EP);
A61P11/02 (EP);
A61P11/06 (EP);
A61P11/08 (EP);
A61P11/16 (EP);
A61P17/00 (EP);
A61P17/06 (EP);
A61P37/08 (EP);
C07D215/227 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/01] | Title | German: | CHINOLINE UND IHRE THERAPEUTISCHE VERWENDUNG | [2010/01] | English: | QUINOLINES AND THEIR THERAPEUTIC USE | [2010/01] | French: | QUINOLÉINES ET LEUR UTILISATION THÉRAPEUTIQUE | [2010/01] | Entry into regional phase | 26.10.2009 | National basic fee paid | 26.10.2009 | Designation fee(s) paid | 26.10.2009 | Examination fee paid | Examination procedure | 26.10.2009 | Examination requested [2010/01] | 26.03.2010 | Despatch of a communication from the examining division (Time limit: M04) | 23.06.2010 | Reply to a communication from the examining division | 12.05.2011 | Communication of intention to grant the patent | 07.09.2011 | Fee for grant paid | 07.09.2011 | Fee for publishing/printing paid | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 26.03.2010 | Opposition(s) | 10.08.2012 | No opposition filed within time limit [2012/42] | Fees paid | Renewal fee | 25.03.2010 | Renewal fee patent year 03 | 26.04.2011 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [DA]WO2005018529 (ASTRAZENECA AB [SE], et al) [DA] 1-12 * example 55 ** claim - * |